548 JOURNAL OF COSMETIC SCIENCE
PA, USA). This assay determines the lowest dilution of the phage cocktail necessary to
diminish biofilms formed by C. acnes.
BLEMISHED THREE-DIMENSIONAL SKIN MODEL
The blemish-prone three-dimensional epidermal skin model was constructed by infusing a
reconstituted human epidermis (RHE, prepared from the foreskin of three Caucasian donors)
with C. acnes (#6919, ThermoFisher Scientific) at levels of approximately 106 colony forming
units (CFU) per milliliter. The bacterial suspensions (diluted in phosphate-buffered saline, PBS)
were topically applied to the RHE and incubated for 72 hours at 37°C. The three individual
C. acnes bacteriophages used in the cocktail were each diluted according to their respective
titers to provide equivalent dosages. The bacteriophage cocktail was incubated on the three-
dimensional RHE for 72 hours after which analyses of tissue toxicity, C. acnes reduction, and
inflammatory factor levels were evaluated relative to an RHE not inoculated with C. acnes.
The evaluation of tissue toxicity was conducted via imaging analysis of the tissue
morphology post-staining with hemalun (J.T. Baker®, Phillipsburg, NJ, USA blue/
purple color that stains nucleic acids) and eosin (Klinipath, Fisher Scientific, Hampton,
NH, USA pink color that stains basic structures such as proteins). For a non-cytotoxic
negative control, the tissue was treated with PBS. For the cytotoxic positive control, the
tissue was treated with 0.1% SDS. Afterwards, the tissue samples were fixed with 4%
paraformaldehyde, dehydrated, and paraffin embedded. The tissue was examined using a
Nikon Ni-E photomicroscope fitted with a Nikon DS-Ri2 camera (Tokyo, Japan).
Relative C. acnes levels were assessed by collecting bacteria with swabs soaked in PBS
containing 0.1% Tween-80, which were then inoculated onto brain-heart infusion media
plates and incubated under anaerobic conditions at 37°C for 5 days. The number of CFUs
were counted and the relative reductions were calculated as described.
Changes in the gene expression of various inflammatory factors (IL-8, MIP-1β, and MCP-1) were
evaluated using TaqMan Gene Expression Assay (Applied Biosystems, Waltham, MA, USA).
Briefly, RNA was collected and purified from the experimental and control tissue samples,
complementary DNA (cDNA) was synthesized, and the relative expression was determined via
reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR) using a QuantStudio7
PCR System (Applied Biosystems) using RPLP0 as a housekeeping gene to normalize against.
The relative expression was calculated as =2−(Ct treated condition Ct reference condition) ,where Ct =Ct
(target gene) Ct (housekeeping gene) in each cDNA sample.
PILOT CLINICAL STUDY
A pilot clinical study was conducted on a group of three female individuals (one Black, one
Caucasian, and one Hispanic/Latino) with mild to moderate blemished skin. Each participant
used a finished formulation containing 1% of the C. acnes targeted triple bacteriophage
cocktail twice daily once in the morning and once in the evening for a total of 7 days. The
participants were examined at baseline, 1 day, 3 days, and 7 days in the 1-week pilot study.
Investigated metrics included sebum levels that were determined using a Sebumeter® SM 815
PC (Courage and Khazaka electronic GmbH, Köln, Germany) and relative coproporphyrin
III fluorescence levels evaluated by porphyrins analysis algorithm on images captured in a
549 Modern Skincare
region of interest by a Canfield research device under UV-fluorescence or red-light modalities.
Finally, the three participants had their skin swabbed (5 samples per participant), which was
tested for relative levels of skin bacterial groups via 16S rRNA sequencing.61
REFERENCES
(1) Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011 9(4):244–253. doi:10.1038/
nrmicro2537
(2) Fournière M, Latire T, Souak D, Feuilloley MGJ, Bedoux G. Staphylococcus epidermidis and Cutibacterium
acnes: two Major Sentinels of Skin microbiota and the Influence of Cosmetics. Microorganisms. 2020 8(11).
doi:10.3390/microorganisms8111752
(3) Brüggemann H, Salar-Vidal L, Gollnick HPM, Lood R. A Janus-faced Bacterium: Host-Beneficial
and -Detrimental Roles of Cutibacterium acnes. Front Microbiol. 2021 12:673845. doi:10.3389/
fmicb.2021.673845
(4) Zheng Y, Hunt RL, Villaruz AE, et al. Commensal Staphylococcus epidermidis contributes to skin
barrier homeostasis by generating protective ceramides. Cell Host Microbe. 2022 30(3):301–313.e9.
doi:10.1016/j.chom.2022.01.004
(5) Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin
microbiome. Science. 2009 324(5931):1190–1192. doi:10.1126/science.1171700
(6) Oh J, Byrd AL, Park M, NISC Comparative Sequencing Program, Kong HH, Segre JA. Temporal
stability of the human skin microbiome. Cell. 2016 165(4):854–866. doi:10.1016/j.cell.2016.04.008
(7) Coenye T, Peeters E, Nelis HJ. Biofilm formation by Propionibacterium acnes is associated with increased
resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol.
2007 158(4):386–392. doi:10.1016/j.resmic.2007.02.001
(8) Williams MR, Gallo RL. The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep.
2015 15(11):65. doi:10.1007/s11882-015-0567-4
(9) Koh LF, Ong RY, Common JE. Skin microbiome of atopic dermatitis. Allergol Int. 2022 71(1):31–39.
doi:10.1016/j.alit.2021.11.001
(10) Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012 379(9813):361–372. doi:10.1016/
S0140-6736(11)60321-8
(11) Fitz-Gibbon S, Tomida S, Chiu B-H, et al. Propionibacterium acnes strain populations in the human
skin microbiome associated with acne. J Invest Dermatol. 2013 133(9):2152–2160. doi:10.1038/jid.2013.21
(12) Kinney MA, Yentzer BA, Fleischer AB, Feldman SR. Trends in the treatment of acne vulgaris: are
measures being taken to avoid antimicrobial resistance? J Drugs Dermatol. 2010 9(5):519–524.
(13) Uhlenhake E, Yentzer BA, Feldman SR. Acne vulgaris and depression: a retrospective examination. J
Cosmet Dermatol. 2010 9(1):59–63. doi:10.1111/j.1473-2165.2010.00478.x
(14) Yentzer BA, Hick J, Reese EL, Uhas A, Feldman SR, Balkrishnan R. Acne vulgaris in the United States:
a descriptive epidemiology. Cutis. 2010 86(2):94–99.
(15) Li ZJ, Choi DK, Sohn KC, et al. Propionibacterium acnes activates the NLRP3 inflammasome in human
sebocytes. J Invest Dermatol. 2014 134(11):2747–2756. doi:10.1038/jid.2014.221
(16) Woese CR, Fox GE. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl
Acad Sci U S A. 1977 74(11):5088–5090. doi:10.1073/pnas.74.11.5088
(17) Grice EA. The skin microbiome: potential for novel diagnostic and therapeutic approaches to cutaneous
disease. Semin Cutan Med Surg. 2014 33(2):98–103. doi:10.12788/j.sder.0087
(18) Grice EA. The intersection of microbiome and host at the skin interface: genomic- and metagenomic-
based insights. Genome Res. 2015 25(10):1514–1520. doi:10.1101/gr.191320.115
(19) Jamal M, Bukhari SMAUS, Andleeb S, et al. Bacteriophages: an overview of the control strategies against
multiple bacterial infections in different fields. J Basic Microbiol. 2019 59(2):123–133. doi:10.1002/
jobm.201800412
Previous Page Next Page